Abstract
For B cells to make antibodies against most antigens, they require help from T cells. T cell help is delivered as two signals to the B cell, one of which is via CD40 and the other can be through receptors for any of a variety of soluble cytokines. We have constructed recombinant vaccinia viruses that express the ligand for CD40 and have shown that the growth of these viruses is dramatically controlled in vivo, even in mice that lack T or B cells. In this paper, we also described our attempts to analyse the CD40 ligand-mediated antiviral activity by studying the clearance of these viruses in mice that are deficient in important antiviral mechanisms. Thus, the antiviral activity of CD40L may represent a surprising and potent effector mechanism of T cells activated during a virus infection.
Similar content being viewed by others
Article PDF
References
Lederman, S. et al. Non-antigen signals for B-cell growth and differentiation to antibody secretion. Curr. Opin. Immun. 5, 439–444 (1993).
Armitage, R.J. et al. Molecular and biological characterization of a murine ligand for CD40. Nature. 357, 80 (1992).
Foy, T.M. et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. II. Prolonged suppression of the humoral immune response by an antibody to the ligand for CD40, gp39. J. exp. Med. 178, 1567–1575 (1993).
Hodgkin, P.D., Yamashita, L.C., Coffman, R.L. & Kehry, M.R. Separation of events mediating B cell proliferation and Ig production by using T cell membranes and lymphokines. J. Immun. 145, 2025 (1990).
Spriggs, M.K. et al. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion. J. exp. Med. 176, 1543 (1992).
Hollenbaugh, D. et al. The human T cell antigen p39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell costimulatory activity. EMBO J. 11, 4313 (1992).
Callard, R.E., Armitage, R.J., Fanslow, W.C. & Spriggs, M.K. CD40 ligand and its role in X-linked hyper-IgM syndrome. Immun. Today 14, 559–564 (1993).
Kawabe, T. et al. The immune responses in CD40-deficient mice: Impaired immunoglobulin class switching and germinal center formation. Immunity 1, 167–178 (1994).
Ramshaw, I., Ruby, J., Ramsay, A., Ada, G. & Karupiah, G. Expression of cytokines by recombinant vaccinia viruses: a model for studying cytokines in virus infections in vivo . Immunol. Rev. 127, 157–182 (1992).
Lane, P. et al. Soluble CD40 ligand can replace the normal T cell-derived CD40 ligand signal to B cells in T cell-dependent activation. J. exp. Med. 177, 1209–1213 (1993).
Bosma, M.J. & Carroll, A.M. The SCID mouse mutant: Definition, characterization, and potential uses. Annu. Rev. Immun. 9, 323–350 (1991).
Ramshaw, I.A., Andrew, M.E., Phillips, S.M., Boyle, D.B. & Coupar, B.E.H. Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection. Nature 329, 545–546 (1987).
Karupiah, G. et al. Elevated natural killer cell responses in mice infected with recombinant vaccinia virus encoding murine IL-2. J. Immun. 144, 290–298. (1990).
Karupiah, G., Blanden, R.V. & Ramshaw, I.A. Interferon γ is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. exp. Med. 172, 1495–1503 (1990).
Wong, G.H.W. & Goeddel, D.V. Tumour necrosis factors α and β inhibit virus replication and synergize with interferons. Nature 323, 819–822 (1986).
Paulie, S. et al. The human B lymphocyte and carcinoma antigen, CDw40, is a phosphoprotein involved in growth signal transduction. J. Immun. 142, 590 (1989).
Schreiver, F. et al. Isolated human follicular dendritic cells display a unique antigenic phenotype. J. exp. Med. 169, 2043 (1989).
Galy, A.H.M. & Spits, H. CD40 is functionally expressed on human thymic epithelial cells. J. Immun. 149, 775 (1992).
Alderson, M.R. et al. CD40 expression by human monocytes: Regulation by cytokines and activation of monocytes by the ligand for CD40. J. exp. Med. 178, 669–674 (1993).
Karupiah, G. et al. Inhibition of viral replication by interferon-γ—induced nitric oxide synthase. Science. 261, 1445–1448 (1993).
Tao, X. & Stout, R.D. T cell-mediated cognate signaling of nitric oxide production by macrophages. Requirements for macrophage activation by plasma membranes isolated from T cells. Eur. J. Immun. 23, 2916–2921 (1993).
Ruby, J. & Ramshaw, I. The antiviral activity of immune CD8+ T cells is dependent on interferon-γ. Lymphok. Cytok. Res. 10, 353–358 (1991).
Huang, S. et al. Immune response in mice that lack the interferon-γ receptor. Science. 259, 1742–1745 (1993).
Sambhi, S.K., Kohonen-Corish, M.R.J. & Ramshaw, I.A. Local production of tumor necrosis factor encoded by recombinant vaccinia virus is effective in controlling viral replication in vivo . Proc. natn. Acad. Sci. U.S.A. 88, 4025–4029 (1991).
Upton, C., Macen, J.L., Schreiber, M. & McFadden, G. Myxoma virus expresses a secreted protein with homology to the tumor necrosis factor receptor gene family that contributes to viral virulence. Virology 184, 370–382 (1991).
Rothe, J. et al. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated cytotoxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364, 798–802 (1993).
Lane, P. et al. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B cells. Eur. J. Immun. 22, 2573–2578 (1992).
Gauchat, J.-F. et al. Induction of human IgE synthesis in B cells by mast cells and basophils. Nature 365, 340–343 (1993).
Notarangelo, L.D., Duse, M. & Ugazio, A.G. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3, 101–122 (1992).
Takebe, Y. et al. SR-alpha promoter: An efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type I long terminal repeat. Molec. cell. Biol. 8, 466–472 (1988).
Brian, A.A. Stimulation of B-cell proliferation by membrane-associated molecules from activated T cells. Proc. natn. Acad. Sci. U.S.A. 85, 564–568 (1988).
Mohler, K. et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. J. Immun. 151, 1548–1561 (1993).
Ruby, J., Fordham, S., Kasprzak, A., Osvath, S. & Ramshaw, I. The immunobiology of murine interleukin-1α encoded by recombinant vaccinia virus. Cytokine. 3, 92–97 (1991).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ruby, J., Bluethmann, H., Aguet, M. et al. CD40 ligand has potent antiviral activity. Nat Med 1, 437–441 (1995). https://doi.org/10.1038/nm0595-437
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm0595-437
This article is cited by
-
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging
Gene Therapy (2014)
-
Immune properties of recombinant vaccinia virus encoding CD154 (CD40L) are determined by expression of virally encoded CD40L and the presence of CD40L protein in viral particles
Cancer Gene Therapy (2004)
-
Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
Cancer Gene Therapy (2002)
-
Getting to know you: Viruses meet CD40 ligand
Nature Medicine (1995)